Roberta Fruttero
Turin, 10125, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
"Nitric Oxide Donors for Biomedical Applications: A Themed Issue Dedicated to Professor Alberto Gasco": Special Issue Editorial Overview.
Journal: Molecules (Basel, Switzerland)
Published: October 02, 2023
Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms.
Journal: Molecules (Basel, Switzerland)
Published: May 30, 2023
NO in Viral Infections: Role and Development of Antiviral Therapies.
Journal: Molecules (Basel, Switzerland)
Published: March 06, 2022
A generator of peroxynitrite activatable with red light.
Journal: Chemical science
Published: June 24, 2021
Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells.
Journal: Bioorganic chemistry
Published: November 20, 2020
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells.
Journal: European journal of medicinal chemistry
Published: August 05, 2020
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: June 02, 2020
NO release regulated by doxorubicin as the green light-harvesting antenna.
Journal: Chemical communications (Cambridge, England)
Published: May 22, 2020
DNA-Targeted NO Release Photoregulated by Green Light.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: March 30, 2020
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 10, 2019
In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin.
Journal: European journal of pharmacology
Published: November 20, 2019
Combination of PDT and NOPDT with a Tailored BODIPY Derivative.
Journal: Antioxidants (Basel, Switzerland)
Published: October 09, 2019
Last Updated: 09/26/2026